The company's strong R&D combined with digital sales channels has attracted investment from Creadev and Jacques Chevallet, former CEO of Arkopharma. Creadev is a family-owned investor that supports businesses with a positive impact on society, while Jacques Chevallet is an industry veteran with extensive experience in the pharmaceutical and health industries.
Nutri&Co has consolidated its scientific expertise and is now looking to accelerate its growth. The funding will be used to expand its product range, increase its presence in international markets, and explore new sales channels. The company's focus on research and development ensures that its products are scientifically tested, safe, and effective.
Nutri&Co's success is due to its ability to combine innovation, research, and a digital approach to sales. By leveraging technology, the company has been able to reach a wider audience and offer products that meet the needs of modern consumers. With this investment, Nutri&Co is well-positioned to continue its growth and expand its reach in the nutraceutical industry.
